Home › Opioid Overdose › NCT07214389
PRoducing Outcome Measures for OTP Quality Improvement
Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On: Project 2 - Producing Outcome Measures for OTP Quality Improvement
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Only BayMark OTPs are eligible for participation.
About the study
This study tests ways to help opioid treatment programs (OTPs) keep patients in care. Staying on methadone or buprenorphine is linked to better outcomes, yet many people leave treatment early. The project will compare two approaches that provide clinics with retention/outcome quality measures and a quality-improvement (QI) toolkit-either alone or with added facilitation-against usual care.
Forty-five BayMark OTPs in multiple states will be randomly assigned to one of three groups: (1) quality measures + QI toolkit; (2) quality measures + QI toolkit + external QI facilitation; or (3) usual care.
The primary outcome is 90-day retention in treatment, measured from OTP electronic health records and Medicaid claims. Secondary outcomes include emergency department visits, hospitalizations, overdoses, and mortality. Findings will identify practical, scalable strategies to improve patient retention in OTPs.
What is being tested
- Quality Measures (Audit and Feedback) (behavioral)
- Quality Improvement (QI) Toolkit (behavioral)
- External QI Facilitation (behavioral)
Sponsor: RTI International · Participants: 4,500 · Started: Oct 3, 2025
Contact the study team
- Tami L Mark, PhD · Phone: 301-816-4612
- Emily C Costilow, MA, PMP · Phone: 910-233-7508
Official record on ClinicalTrials.gov — NCT07214389
Locations in the U.S.
| North Carolina | RTI International, Research Triangle Park |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.